Sign in

CIK 0001357874

  • Non-accelerated filer
  • Smaller reporting company

PRECISION BIOSCIENCES INC

Sign in to watch
Ticker
DTIL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
May 21
Incorporated
DE
Entity type
Operating
Phone
+1 919-314-5512
Business address
302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
  1. 4 Open-market sale Chief Medical Officer sold 7,775 shares at $2.10 ($16,328)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Open-market buy Chief Financial Officer bought 16,677 shares at $3.08 ($51,365)
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Grant or award VP & Corporate Controller acquired 2,659 shares (grant or award)
  8. 4 Grant or award General Counsel and Secretary acquired 10,573 shares (grant or award)
  9. 4 Grant or award Chief Financial Officer acquired 3,712 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 3 Insider Initial Statement of Ownership
  12. 4 Derivatives Options or other derivatives
  13. 3 Insider Initial Statement of Ownership
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market sale Chief Operating Officer sold 30,000 shares at $10.65 ($319,500)
  17. 4 Open-market sale Chief Operating Officer sold 15,000 shares at $10.77 ($161,550)
  18. 4 Open-market sale Chief Operating Officer sold 20,000 shares at an average $10.72 ($214,400)
  19. 4 Open-market sale Chief Operating Officer sold 2,858 shares at $11.20 ($32,010)
  20. 4 Open-market sale Chief Operating Officer sold 30,000 shares at $11.52 ($345,600)

Page 9 of 14 · 269 filings